LH LABORATORY CORP AMER HLDGS

Ownership history in Bridgefront Capital, LLC  ·  8 quarters on record

This page tracks every 13F SEC filing in which Bridgefront Capital, LLC reported a position in LABORATORY CORP AMER HLDGS (LH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.78% (2024 Q1)
Avg. % of fund
0.32%
First filed
2020 Q4
Last filed
2025 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 1,670 +563 +50.9% 0.14% $479K $285.58
2024 Q2 REDUCED 1,107 -3,581 -76.4% 0.09% $225K $199.55
2024 Q1 ADDED 4,688 +1,993 +74.0% 0.78% $1.0M $213.43
2023 Q2 ADDED 2,695 +491 +22.3% 0.35% $650K $200.52
2023 Q1 ADDED 2,204 +1,125 +104.3% 0.31% $506K $189.99
2022 Q1 ADDED 1,079 +213 +24.6% 0.35% $284K $215.84
2021 Q4 REDUCED 866 -2,515 -74.4% 0.26% $272K $257.22
2020 Q4 INITIATED 3,381 0.24% $688K $166.63
% of Fund (quarterly)    LH price (monthly, adj. close)
← Back to Bridgefront Capital, LLC Holdings